- Home
- SMMT vs CYBR Comparison
SMMT vs CYBR Comparison
Compare SMMT & CYBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMMT
- CYBR
- Stock Information
- Founded
- SMMT 2003
- CYBR 1999
- Country
- SMMT United States
- CYBR Israel
- Employees
- SMMT N/A
- CYBR N/A
- Industry
- SMMT Biotechnology: Pharmaceutical Preparations
- CYBR Computer Software: Prepackaged Software
- Sector
- SMMT Health Care
- CYBR Technology
- Exchange
- SMMT Nasdaq
- CYBR Nasdaq
- Market Cap
- SMMT 14.5B
- CYBR 12.4B
- IPO Year
- SMMT N/A
- CYBR 2014
- Fundamental
- Price
- SMMT $18.31
- CYBR $305.27
- Analyst Decision
- SMMT Strong Buy
- CYBR Strong Buy
- Analyst Count
- SMMT 4
- CYBR 29
- Target Price
- SMMT $34.75
- CYBR $327.10
- AVG Volume (30 Days)
- SMMT 2.1M
- CYBR 558.4K
- Earning Date
- SMMT 10-30-2024
- CYBR 11-13-2024
- Dividend Yield
- SMMT N/A
- CYBR N/A
- EPS Growth
- SMMT N/A
- CYBR N/A
- EPS
- SMMT N/A
- CYBR 0.27
- Revenue
- SMMT N/A
- CYBR $909,462,000.00
- Revenue This Year
- SMMT N/A
- CYBR $27.72
- Revenue Next Year
- SMMT N/A
- CYBR $23.19
- P/E Ratio
- SMMT N/A
- CYBR $1,050.02
- Revenue Growth
- SMMT N/A
- CYBR 30.31
- 52 Week Low
- SMMT $1.88
- CYBR $185.04
- 52 Week High
- SMMT $33.89
- CYBR $318.16
- Technical
- Relative Strength Index (RSI)
- SMMT 41.16
- CYBR 62.39
- Support Level
- SMMT $19.01
- CYBR $288.00
- Resistance Level
- SMMT $22.53
- CYBR $318.16
- Average True Range (ATR)
- SMMT 1.45
- CYBR 10.62
- MACD
- SMMT -0.21
- CYBR 1.56
- Stochastic Oscillator
- SMMT 4.85
- CYBR 72.27
About SMMT Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
About CYBR CyberArk Software Ltd.
CyberArk is a cybersecurity vendor focused on the identity market. The company's core privileged access management offering is a market leader within that subsegment, with more than half of the Fortune 500 CyberArk customers. The identity security vendor was founded in 1999 and has around 9,000 customers across various industries. While historically, CyberArk has sold its security solutions primarily via on-premises licenses, over the past few years, it has transitioned to a subscription, recurring revenue model.